Clear Street Markets LLC Gilead Sciences, Inc. Put Options Transaction History

Clear Street Markets LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $922,336 - $1.32 Million	14,800 New	14,800 $1.27 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $5.57 Million - $6.97 Million	-96,100 Reduced 90.57%	10,000 $595,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $6.86 Million - $7.79 Million	105,752 Added 30388.51%	106,100 $7.7 Million
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $18,276 - $19,718	-270 Reduced 43.69%	348 $2.43 Million
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $23,356 - $25,520	368 Added 147.2%	618 $4.26 Million
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $6,600 - $7,530	-110 Reduced 30.56%	250 $1.62 Million
Q4 2020 Feb 25, 2021	SELL	$56.65 - $64.55 $15,748 - $17,944	-278 Reduced 43.57%	360 $20,000
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $20,989 - $26,391	338 Added 112.67%	638 $4.03 Million
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $7,234 - $8,400	100 Added 50.0%	300 $2.31 Million
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $15,406 - $19,734	-246 Reduced 55.16%	200 $1.5 Million
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $3,758 - $4,134	61 Added 15.84%	446 $2.9 Million
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $2,751 - $3,082	44 Added 12.9%	385 $2.5 Million
Q4 2018 Jan 23, 2019	BUY	$60.54 - $79.0 $17,738 - $23,147	293 Added 610.42%	341 $2.13 Million
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $194 - $227	3 Added 6.67%	48 $340,000
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $946 - $1,154	13 Added 40.63%	45 $339,000
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $2,307 - $2,735	32	32 $259,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.